From: Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia
Model cycle
From response to
From no response to
Response
No response
1
0.000
0.539
0.461
2
0.843
0.157
0.278
0.722
3
0.878
0.122
0.248
0.752